SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
China Medicine Corporation (CHME) trades at a trailing P/E of 0.2. Trailing earnings yield is 555.56%.
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (0.2); earnings yield beats bond yields (555.56%).
- Trailing Earnings Yield 555.56% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 65/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CHME
Valuation Multiples
P/E (TTM)0.2
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.11
Book Value / Share$0.00
Revenue / Share$4.20
FCF / Share$0.00
Yields & Fair Value
Earnings Yield555.56%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2004 |
$0.39 |
$10.4M |
$2.94M |
28.3% |
| 2005 |
$-0.01 |
$0.00 |
$-32.5K |
- |
| 2006 |
$0.63 |
$23.99M |
$4.79M |
20% |
| 2007 |
$0.50 |
$42.11M |
$6.88M |
16.3% |
| 2008 |
$0.60 |
$53.65M |
$9.13M |
17% |
| 2009 |
$0.11 |
$64.75M |
$1.72M |
2.7% |
